Origins of timed cancer treatment: Early marker rhythm-guided individualized chronochemotherapy

Journal of Experimental Therapeutics and Oncology

Volumn 6, Issue 1, 2006, Pages 55-61

  Halberg, Franz ^a   Prem, Konald ^a   Halberg, Francine ^b   Norman, Catherine ^a   Cornélissen, Germaine ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Marin Radiation Oncology Medical Group   (United States)

Author keywords

Chronotherapy; Circadian; Malignant ovarian endodermal sinus tumor (yolk sac carcinoma); Marker rhythm; Tumor marker

Indexed keywords

AMPICILLIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ERYTHROMYCIN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ABDOMINAL PAIN; ADULT; BLOOD CELL COUNT; CANCER THERAPY; CASE REPORT; CHRONOCHEMOTHERAPY; CHRONOTHERAPY; CIRCADIAN RHYTHM; CONFERENCE PAPER; DISEASE FREE SURVIVAL; FEMALE; FUNCTIONAL STATUS; HUMAN; INDIVIDUALIZATION; MOOD; NAUSEA; OPTIMAL DRUG DOSE; OVARY CANCER; PARESTHESIA; PATIENT MONITORING; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TEMPERATURE MEASUREMENT; TREATMENT OUTCOME; YOLK SAC TUMOR; ANIMAL; ARTICLE; CHRONOBIOLOGY; METHODOLOGY; MIDDLE AGED; MOUSE; NEOPLASM; OVARY TUMOR; PERITONEUM TUMOR; TIME;

ANIMALS; ANTINEOPLASTIC AGENTS; CHRONOBIOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MICE; MIDDLE AGED; NEOPLASMS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33846049655     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Forney JP, Di Saia PJ, Morrow CP. Endodermal sinus tumor: a report of two sustained remissions treated postoperatively with a combination of actinomycin D. 5-fluorouracil, and cyclophosphamide. Obstetrics and Gynecology 1975; 45: 186-189.
2. Halberg F, Buchwald H, Charyulu K, Reeker E. Autorhythmometry and cancer of the breast: a case report. In: Scheving LE, Halberg P, Pauly JE, editors. Chronobiology, Proc. Int. Soc. for the Study of Biological Rhythms. Stuttgart: Georg Thieme Publishers/Tokyo: Igaku Shoin Ltd.: 1974. p. 293-298.
3. Charyulu K, Halberg F, Reeker E, Buchwald H. Autorhythmometry in relation to radiotherapy: Case report as tentative feasibility check. In: Scheving LE, Halberg F, Pauly JE, editors. Chronobiology, Proc. Int. Soc. for the Study of Biological Rhythms. Stuttgart: Georg Thieme Publishers/Tokyo: Igaku Shoin Ltd.: 1974. p. 265-272.
4. Halberg F. Biological as well as physical parameters relate to radiology. Guest Lecture, Proc. 30th Ann. Cong. Rad., January 1977, Post-Graduate Institute of Medical Education and Research, Chandigarh, India, 8 pp.
5. Halberg F, Cornélissen G, Wang ZR, Wan C, Ulmer W, Katinas G, Singh Ranjana, Singh RK, Singh Rajesh, Gupta BD, Singh RB, Kumar A, Kanabrocki E, Sothern RB, Rao G, Bhatt MLBD, Srivastava M, Rai G, Singh S, Pati AK, Nath P, Halberg Francine, Halberg J, Schwartzkopff O, Bakken E, Shastri VK. Chronomics: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond. J Exp Therapeutics Oncol 2003; 3: 223-260.
6. Halberg F, Cornelissen G, Bingham C, Fujii S, Halberg E. From experimental units to unique experiments: chronobiologic pilots complement large trials, in vivo 1992; 6: 403-428.
7. Haus E, Fernandes G, Kühl JFW, Yunis EJ, Lee JK, Halberg F. Murine circadian susceptibility rhythm to cyclophosphamide. Chronobiologia 1974; 1: 270-277.
8. Jeyakumar A, Chalas E, Hindenburg A. Sustained complete remission in a patient with platinum-resistant ovarian yolk sac tumor. Gynecologic Oncology 2001; 81: 578-580.
9. Haus E, Halberg F, Scheving L, Pauly JE, Cardoso S, Kühl JFW, Sothern R, Shiotsuka RN, Hwang DS. Increased tolerance of leukemic mice to arabinosyl cytosine given on schedule adjusted to circadian system. Science 1972; 177: 80-82.
10. Halberg F, Haus E, Cardoso SS, Scheving LE, Kühl JFW, Shiotsuka R, Rosene G, Pauly JE, Runge W, Spalding JF, Lee JK, Good RA. Toward a chronotherapy of neoplasia: Tolerance of treatment depends upon host rhythms. Experientia (Basel) 1973; 29: 909-934.
11. Halberg F, Nelson W, Cornélissen G, Haus E, Scheving LE, Good RA. On methods for testing and achieving cancer chronotherapy. Cancer Treatment Rep 1979; 63: 1428-1430.
12. Rose WC, Trader MW, Laster WR Jr, Schabel FM Jr. Chronochemotherapy of L1210 leukemic mice with cytosine arabinoside or cyclophosphamide. Cancer Treatment Rep 1978; 62: 1337-1349.
13. Cornélissen G, Halberg F. Introduction to Chronobiology. Medtronic Chronobiology Seminar #7, April 1994, 52 pp. (Library of Congress Catalog Card #94-060580) http://www.msi.umn.edu/~halberg/
14. Portela A, Cornélissen G, Halberg Franz, Bast RC Jr, Fujii S, Xu FJ, Yu YH, Takagi M, Halberg J, Halberg Francine, Berg H, O'Brien T, Walker R, Haus E, Halberg E. Spectral differences between epitopes in the chronomes of salivary CA130 and CA125. In vivo 1995; 9: 341-346.
15. Mormont MC, Levi F. Cancer chronotherapy: principles, applications, and perspectives. Cancer 2003; 97: 155-169.
16. Gallion HH, Brunetto VL, Cibuli M, Lentz SS, Reid G, Soper JT, Burger RA, Andersen W. Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in Stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21: 3808-3813.
17. Gallion HH, Brunetto (Filiaci) VL. In reply (to Hrushesky et al. J Clin Oncol 2004; 22: 2971-2972). J Clin Oncol 2004; 22: 2972.
18. Hrushesky W, Wood P, Levi F, Roemeling R v, Bjarnason G, Focan C, Meier K, Cornélissen G, Halberg F. A recent illustration of some essentials of circadian chronotherapy study design. J Clin Oncol 2004; 22: 2971-2972.
19. Halberg F. The week in phylogeny and ontogeny: opportunities for oncology. In vivo 1995; 9: 269-278.
20. Kennedy BJ. A lady and chronobiology. Chronobiologia 1993; 20: 139-144.
21. Deka B, Deka AC, Patil RB, Halberg F. In-phase synchronization of circadian temperature rhythm of cancerous and healthy mouth tissue. Int J Chronobiol 1981; 7: 226.
22. Gupta BD, Cornélissen G, Halberg F, Verina G. Oral and cervical temperature as marker variables for chronoradiotherapy of patients with cervical cancer. Progress in Clinical and Biological Research 1987; 227B: 349-356.
23. Gautheric M, Gros Ch. Circadian rhythm alteration of skin temperature in breast cancer. Chronobiologia 1977; 4: 1-17.
24. Halberg E, Halberg F, Cornélissen G, Garcia-Sainz M, Simpson HW, Taggett-Anderson MA, Haus E. Toward a chronopsy: Part II. A thermopsy revealing asymmetrical circadian variation in surface temperature of human female breasts and related studies. Chronobiologia 1979; 6: 231-257.
25. Wang ZR, Wan CM, Lei Y, Cornélissen G, Halberg F. Phase-zero trial of clinical chronoradiotherapy of lung cancer. Chronobiologia 1994; 21: 155-157.
26. Hrushesky WJM. Automatic chronotherapy: an integral part of the future of medicine. In: Hekkens WThJM, Kerkhof GA, Rietveld WJ, eds. Trends in chronobiology. Oxford: Pergamon Press; 1988. p. 281-293.
27. Halberg E, Long HJ III, Cornélissen G, Blank MA, Elg S, Touitou Y, Bakken E, Delmore P, Haus E, Sackett-Lundeen L, Prem K, Halberg F. Toward a chronotherapy of ovarian cancer with taxol: Part II: Test pilot study on CA125. Chronobiologia 1992; 19: 17-42.
28. Carlebach R, Ashkenazi IE. Temporal disorder: therapeutic considerations. Chronobiologia 1987; 14: 162.
29. Fossel M. Editor's Note [to Halberg F, Cornélissen G, Halberg J, Fink H, Chen C-H, Otsuka K, Watanabe Y, Kumagai Y, Syutkina EV, Kawasaki T, Uezono K, Zhao ZY, Schwartzkopff O. Circadian Hyper-Amplitude-Tension, CHAT: a disease risk syndrome of anti-aging medicine]. J Anti-Aging Med 1998; 1: 239.
30. Halberg F, Cornélissen G, Halberg J, Schwartzkopff O. Prehypertensive and other variabilities also await treatment. Am J Medicine, in press.
31. Cornélissen G, Chen CH, Halberg F. Predictive value of blood pressure variability: merits of circadian parameters versus dipping patterns. New England J Medicine 2006; 355: 850-851.
32. Cornélissen G, Delcourt A, Toussaint G, Otsuka K, Watanahe Y, Siegelova J, Fiser B, Dusek J, Homolka P, Singh RB, Kumar A, Singh RK, Sanchez S, Gonzalez C, Holley D, Sundaram B, Zhao Z, Tomlinson B, Fok B, Zeman M, Dulkova K, Halberg F. Opportunity of detecting pre-hypertension: worldwide data on blood pressure overswinging. Biomedicine & Pharmacotherapy 2005; 59 (Suppl 1): S152-S157.